Literature DB >> 9178887

Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas.

V Shridhar1, L Wang, R Rosati, W Paradee, R Shridhar, C Mullins, W Sakr, D Grignon, O J Miller, Q C Sun, J Petros, D I Smith.   

Abstract

The constitutive fragile site at chromosomal band 3p14.2, FRA3B, is the most active common fragile site in the human genome. We have localized aphidicolin-induced breakpoints to two distinct clusters, separated by 200 Kb, in FRA3B (Paradee et al., 1996). Sequence analysis of these regions identified two polymorphic microsatellite markers immediately adjacent to each of these breakpoint clusters. In this report we have used these two new microsatellites and 14 additional 3p microsatellites to analyse chromosome 3p breakage and loss in 94 sporadic RCC samples, including nonpapillary, papillary and oncocytomas. We have found heterozygous loss of 3p14 sequences in >60% of the RCC samples, including both clear cell and papillary renal cell carcinomas. We have found frequent breakage in the region immediately surrounding FRA3B, demonstrating that FRA3B does play a role in chromosome breakage and loss in RCC. In contrast to other reports, >50% of the papillary tumors also showed LOH of 3p markers. We also observed microsatellite instability (MIN) with most of the tested markers in seven of eight oncocytomas and one of 69 clear cell carcinomas. The MIN in some oncocytomas was of the RER+ (replication error) type I phenotype. None of the five 3p14.2 markers detected any homozygous deletions in tumor samples, but 69/94 (73%) of the tumors had LOH for the region, which includes the recently identified FHIT gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178887     DOI: 10.1038/sj.onc.1201100

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  Purification and crystallization of complexes modeling the active state of the fragile histidine triad protein.

Authors:  C Brenner; H C Pace; P N Garrison; A K Robinson; A Rosler; X H Liu; G M Blackburn; C M Croce; K Huebner; L D Barnes
Journal:  Protein Eng       Date:  1997-12

Review 2.  Renal hypoxia-HIF-PHD-EPO signaling in transition metal nephrotoxicity: friend or foe?

Authors:  Frank Thévenod; Timm Schreiber; Wing-Kee Lee
Journal:  Arch Toxicol       Date:  2022-04-21       Impact factor: 6.168

Review 3.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.